IL-17–producing γδ T cells in the tumor microenvironment promote radioresistance in mice
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci193945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Yue Deng und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Union Hospital, Tongji Medical College and. Hauptthemen laut MEDLINE: Tumor Microenvironment, Interleukin-17, Radiation Tolerance, Receptors, Antigen, T-Cell, gamma-delta. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key R&D Program of Hubei Province, Chinese Society of Clinical Oncology Foundation.
Abstract (Originalsprache)
The immunosuppressive tumor microenvironment (TME) drives radioresistance, but the role of γδ T cells in regulating radiosensitivity remains incompletely understood. In this study, we found that γδ T cell infiltration in the TME substantially increased after radiotherapy and contributed to radioresistance. Depletion of γδ T cells enhanced radiosensitivity. Single-cell RNA-seq revealed that γδ T cells in the postradiotherapy TME were characterized by the expression of Zbtb16 , Il23r , and Il17a , and served as the primary source of IL-17A. These γδ T cells promoted radioresistance by recruiting myeloid-derived suppressor cells and suppressing T cell activation. Mechanistically, radiotherapy-induced tumor cell–derived microparticles containing dsDNA activated the cGAS-STING/NF-κB signaling pathway in macrophages, upregulating the expression of the chemokine CCL20, which was critical for γδ T cell recruitment. Targeting γδ T cells and IL-17A enhanced radiosensitivity and improved the efficacy of radiotherapy combined with anti-PD-1 immunotherapy, providing potential therapeutic strategies to overcome radioresistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Center, Union Hospital, Tongji Medical College and.
- Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, China.
- Key Laboratory of Biological Targeted Therapy (Huazhong University of Science and Technology), Ministry of Education, Wuhan, Hubei, China.
- Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
Förderung
- National Natural Science Foundation of China
- Key R&D Program of Hubei Province
- Chinese Society of Clinical Oncology Foundation
- Natural Science Foundation of Hubei Province
- the Open Research Fund of Hubei Key Laboratory of Precision Radiation Oncology
Zitieren
APA
Deng, Y., Liu, X., Yang, X., Wei, W., Wang, J., Yang, Z., Sun, Y., Hu, Y., Zhang, H., Wang, Y., Zhang, Z., Wen, L., Huang, F., Yang, K., & Wan, C. (2025). IL-17–producing γδ T cells in the tumor microenvironment promote radioresistance in mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci193945
Vancouver
Deng Y, Liu X, Yang X, Wei W, Wang J, Yang Z, et al. IL-17–producing γδ T cells in the tumor microenvironment promote radioresistance in mice. Journal of Clinical Investigation. 2025. doi:10.1172/jci193945
BibTeX
@article{Deng2025,
author = {Deng, Yue and Liu, Xixi and Yang, Xiao and Wei, Wenwen and Wang, Jiacheng and Yang, Zheng and Sun, Yajie and Hu, Yan and Zhang, Haibo and Wang, Yijun and Zhang, Zhanjie and Wen, Lu and Huang, Fang and Yang, Kunyu and Wan, Chao},
title = {IL-17–producing γδ T cells in the tumor microenvironment promote radioresistance in mice},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci193945}
}
EUVIMED